Click here to view the embedded video.

Click here to view the embedded video.

About Malcolm Gladwell:
Malcolm Gladwell specializes in surprises — counterintuitive truths discovered by clever researchers, obscure historians, and ordinary people observing the world. In his first year as a staff writer at the “New Yorker in 1996, he captivated readers with an article titled “The Tipping Point,” which grappled with a mysterious sudden drop in New York City crime, by applying the principles of epidemiology to policing. “The Tipping Point” ultimately became a book and has remained on the New York Times best-seller lists for years.

Meanwhile, Gladwell has gone on to explore similar mismatches — mammography and fighter jets (it’s all about seeing), pit bulls and racial profiling, Wayne Gretsky and Yo-Yo Ma — writing cross-disciplinary articles that illuminate hidden facts about group behavior, business and individual selves. Gladwell began 2007 with a controversial look at the Enron case, distinct from all the reportage that’s come before.

He advocates taking problems slowly – noting that expertise comes with approx. 10,000 hours of training. He thereby identifies the ‘mismatch problem’, which is simply the idea that standards used to judge/predict success in a given field don’t match what it takes to be successful in that field.

For example, when diagnosing colonoscopies, it’s how much time the doctor spends on each colonoscopy, not how smart they are, how much training they have, where s/he went to school etc. that determines success. If you spend more than 10 minutes on each colonoscopy rather than one, you’ll find the cancers. However, we select and train doctors for their cognitive facility, for, amongst other things, the speed at which they acquire information and the efficiency with which they go about their tasks.

Click here to view the embedded video.

About Malcolm Gladwell:
Malcolm Gladwell specializes in surprises — counterintuitive truths discovered by clever researchers, obscure historians, and ordinary people observing the world. In his first year as a staff writer at the “New Yorker in 1996, he captivated readers with an article titled “The Tipping Point,” which grappled with a mysterious sudden drop in New York City crime, by applying the principles of epidemiology to policing. “The Tipping Point” ultimately became a book and has remained on the New York Times best-seller lists for years.

Meanwhile, Gladwell has gone on to explore similar mismatches — mammography and fighter jets (it’s all about seeing), pit bulls and racial profiling, Wayne Gretsky and Yo-Yo Ma — writing cross-disciplinary articles that illuminate hidden facts about group behavior, business and individual selves. Gladwell began 2007 with a controversial look at the Enron case, distinct from all the reportage that’s come before.

About Dr. Safi R. Bahcall:
Dr. Safi R. Bahcall is the Founder, Chief Executive Officer, President, and Director at Synta Pharmaceuticals, a drug discovery and development company with three drugs entering clinical trials for cancer and autoimmune diseases. He is also an Advisor at SCIUS Capital Group, Investment Arm. Mr. Bahcall is a former McKinsey & Co. Consultant with more than 15 years experience.

Synta Pharmaceuticals Corp. is a biopharmaceutical company, focuses on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. The company’s product pipeline primarily includes STA-4783, a Phase IIb clinical trial for the treatment of metastatic melanoma, as well as in Phase IIb clinical trial for the treatment of additional cancers. The company’s drug candidates also include, Apilimod (STA-5326), a Phase IIa clinical trial in patients with rheumatoid arthritis, as well as sponsoring a Phase IIa clinical trial in patients with common variable immunodeficiency (CVID). In addition, the company develops STA-9090 and STA-9584, which are in preclinical development; and Oral CRAC ion channel inhibitor program that is in the lead optimization stage for the treatment of autoimmune diseases. The company, formerly known as Neutra Pharmaceuticals Corp., was incorporated in 2000 and is based in Lexington, Massachusetts.

Click here to view the embedded video.

About Malcolm Gladwell:
Malcolm Gladwell specializes in surprises — counterintuitive truths discovered by clever researchers, obscure historians, and ordinary people observing the world. In his first year as a staff writer at the “New Yorker in 1996, he captivated readers with an article titled “The Tipping Point,” which grappled with a mysterious sudden drop in New York City crime, by applying the principles of epidemiology to policing. “The Tipping Point” ultimately became a book and has remained on the New York Times best-seller lists for years.

Meanwhile, Gladwell has gone on to explore similar mismatches — mammography and fighter jets (it’s all about seeing), pit bulls and racial profiling, Wayne Gretsky and Yo-Yo Ma — writing cross-disciplinary articles that illuminate hidden facts about group behavior, business and individual selves. Gladwell began 2007 with a controversial look at the Enron case, distinct from all the reportage that’s come before.

Click here to view the embedded video.

About Mike McCready:
Mike McCready is an entrepreneur and executive in the international music industry and has been referred to as the founder of the field of Music Intelligence. Mike grew up in both Ord and Broken Bow, Nebraska and now lives in Manhattan and Barcelona. He currently serves as CEO of Platinum Blue Music Intelligence a company he co-founded with another leader in the music intelligence field, Tracie Reed.

Platinum Blue uses technology to analyze the underlying mathematical properties of music in order to generate insightful music recommendations and to help create and market hit songs for major music labels and top producers. Before co-founding Platinum Blue he co-founded and served as CEO at Polyphonic HMI from November 2001 to December 2005.

He has recently joined the advisory board of an exciting company in Dallas, Texas called Dremāk. The company is installing mini-recording and audition studios in shopping malls and commercial centers which will allow budding artists to record demos, audition for opportunities in Hollywood or Broadway without having to travel or just have a professional record of their work.

About Malcolm Gladwell:
Malcolm Gladwell specializes in surprises — counterintuitive truths discovered by clever researchers, obscure historians, and ordinary people observing the world. In his first year as a staff writer at the “New Yorker in 1996, he captivated readers with an article titled “The Tipping Point,” which grappled with a mysterious sudden drop in New York City crime, by applying the principles of epidemiology to policing. “The Tipping Point” ultimately became a book and has remained on the New York Times best-seller lists for years.

Meanwhile, Gladwell has gone on to explore similar mismatches — mammography and fighter jets (it’s all about seeing), pit bulls and racial profiling, Wayne Gretsky and Yo-Yo Ma — writing cross-disciplinary articles that illuminate hidden facts about group behavior, business and individual selves. Gladwell began 2007 with a controversial look at the Enron case, distinct from all the reportage that’s come before.

Click here to view the embedded video.

About Malcolm Gladwell:
Malcolm Gladwell specializes in surprises — counterintuitive truths discovered by clever researchers, obscure historians, and ordinary people observing the world. In his first year as a staff writer at the “New Yorker in 1996, he captivated readers with an article titled “The Tipping Point,” which grappled with a mysterious sudden drop in New York City crime, by applying the principles of epidemiology to policing. “The Tipping Point” ultimately became a book and has remained on the New York Times best-seller lists for years.

Meanwhile, Gladwell has gone on to explore similar mismatches — mammography and fighter jets (it’s all about seeing), pit bulls and racial profiling, Wayne Gretsky and Yo-Yo Ma — writing cross-disciplinary articles that illuminate hidden facts about group behavior, business and individual selves. Gladwell began 2007 with a controversial look at the Enron case, distinct from all the reportage that’s come before.